Hitachi Healthcare Americas and Terason Announce Strategic Partnership for Sale and Distribution of uSmart® 3200T NexGen Ultrasound System
Cleveland, OH June 5, 2017 — Hitachi Healthcare Americas Corporation (HHA) and Terason announced the signing of a strategic partnership for the sale and distribution of the uSmart® 3200T NexGen Ultrasound System focusing on urology. “This agreement fills a need for both companies,” explained Jeff Sirek, General Manager of Terason. “Terason gains an expanded sales channel and HHA adds a solution to address specific market needs that we both believe are poised for significant growth over the next several years.” Mr. Sirek went on to explain that “in addition to co-marketing, both companies are also collaborating to expand the versatility of the 3200T within several unique and niche markets.”
The agreement reflects a larger strategy that has served as an ongoing guiding philosophy for Hitachi Healthcare, says John Waddell, Vice President / General Manager of Ultrasound at HHA. “We are continually looking for ways that HHA can respond rapidly to the ever-changing landscape of medical imaging and provide our customers with comprehensive ultrasound solutions. This partnership with Terason is a great example of this because the result is more than just the sum of its parts.”
Hitachi Healthcare showcased the Terason uSmart 3200T NexGen at this year’s American Urological Association (AUA) in Boston and received a very favorable response from customers and attendees. “The level of traffic at the uSmart display was indicative of the desire for such a unique value proposition and that certainly resonated with attendees,” reported Mr. Waddell.
Hitachi Healthcare Americas Corporation, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Healthcare Business Unit, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at www.hitachi.com.
Hitachi Healthcare Americas Corporation